{"protocolSection": {"identificationModule": {"nctId": "NCT03161158", "orgStudyIdInfo": {"id": "UF-HF-02-INT"}, "secondaryIdInfos": [{"id": "EUDAMED-No. CIV -17-01-018204", "type": "OTHER", "domain": "European Medicines Agency"}], "organization": {"fullName": "Fresenius Medical Care Deutschland GmbH", "class": "INDUSTRY"}, "briefTitle": "PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure", "officialTitle": "PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure"}, "statusModule": {"statusVerifiedDate": "2020-07", "overallStatus": "TERMINATED", "whyStopped": "Low recruitment", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-11-03", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-08-26", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-08-26", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-05-02", "studyFirstSubmitQcDate": "2017-05-18", "studyFirstPostDateStruct": {"date": "2017-05-19", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2020-12-16", "resultsFirstSubmitQcDate": "2021-04-08", "resultsFirstPostDateStruct": {"date": "2021-05-05", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-04-08", "lastUpdatePostDateStruct": {"date": "2021-05-05", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Fresenius Medical Care Deutschland GmbH", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "This study evaluates whether tailored, peripheral ultrafiltration complementary to low-dose diuretics is associated with a reduction in cardiovascular mortality in 90 days after randomization and heart failure events in 90 days after discharge than usual care including stepped intravenous diuretics in acutely decompensated chronic heart failure with fluid overload (not fully responsive to diuretic therapy).", "detailedDescription": "The study will evaluate whether stepped, peripheral ultrafiltration complementary to low-dose diuretics influences 90-day clinical outcomes compared to usual care including intravenous diuretics in symptomatic heart failure patients with persistent congestion. Hospitalized subjects will be randomly assigned to receive either a tailored, peripheral ultrafiltration approach complementary to intravenous low-dose diuretics and other guideline-directed medical therapy OR high-dose diuretic therapy and other Guideline-directed medical therapy."}, "conditionsModule": {"conditions": ["Heart Failure", "Acute Heart Failure"], "keywords": ["Cardio-Renal Syndrome type 1", "Acutely decompensated chronic heart failure", "Ultrafiltration"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "interventionModelDescription": "Multicenter, prospective, randomized, parallel-group, controlled", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 62, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Ultrafiltration Group", "type": "ACTIVE_COMPARATOR", "description": "Veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm.", "interventionNames": ["Device: CHIARA-System"]}, {"label": "Control group (Usual care IV diuretics)", "type": "OTHER", "description": "Guideline-directed therapy including IV loop diuretics according to treatment algorithm.", "interventionNames": ["Other: Usual care IV diuretics"]}], "interventions": [{"type": "DEVICE", "name": "CHIARA-System", "description": "Treatment with veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm. 1-7 Ultrafiltration sessions (6-10h/session, number of sessions depending on clinical assessment) for at least 1-2 consecutive days and a maximum of 7 days.", "armGroupLabels": ["Ultrafiltration Group"], "otherNames": ["Low-dose IV diuretics"]}, {"type": "OTHER", "name": "Usual care IV diuretics", "description": "Guideline-directed therapy including IV loop diuretics (according to treatment algorithm)", "armGroupLabels": ["Control group (Usual care IV diuretics)"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Heart Failure (HF) Event", "description": "Heart failure hospitalization or unscheduled outpatient or emergency department treatment with IV loop diuretics or ultrafiltration.", "timeFrame": "in 90 days after discharge"}, {"measure": "Cardiovascular Death up to 90 Days After Randomization.", "description": "The rationale for the follow up time period of 90 days is that death rates reported in previous acute HF trials indicate that mortality seems to become linear after \\~60-90 days post discharge Collection for Cardiovascular Trials initiative definition of cardiovascular death includes death resulting from an acute myocardial infarction, sudden cardiac death, death due to heart failure, death due to stroke, and death due to other cardiovascular causes", "timeFrame": "in 90 days after discharge"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\nGeneral:\n\nInformed consent signed and dated by study patient and investigator/authorised physician\n\n* Minimum age of 18 years\n* Ability to understand the nature and requirements of the study\n\nStudy-specific:\n\n* Heart failure patients with preserved, mid-range or reduced ejection fraction (confirmed according to the current definitions of heart failure with preserved (HFpEF), mid-range (HFmrEF) and reduced ejection fraction (HFrEF) requiring echocardiographic assessment within the prior 12 months) who are admitted to the hospital due to signs/symptoms of congestion (left- or right sided)\n* On regularly scheduled oral loop diuretics prior to admission\n* Patients who have received IV loop diuretics for decongestion within 24 hours after hospital admission and prior to screening. The dosages are administered according to clinical judgment.\\*\\* (\\*\\*This inclusion criterion was changed with CIP amendment; in former version 3.0 it read \"After pre-screening and prior to final screening for eligibility, patients who have received two boluses of IV loop diuretics (Dose according to the Furosemide-Low Intensification, Q12 hour bolus arm of the DOSE trial))\n* Symptoms of congestion and clinical evidence at the time of final screening for eligibility:\n* Fluid overload manifested by at least 2 of the following:\n\n  1. Pitting edema \u22652+ of the lower extremities\n  2. Jugular venous pressure \\>8 cm H2O\n  3. Pulmonary congestion or pleural effusion on chest x-ray\n  4. Paroxysmal nocturnal dyspnea or \u22652- pillow orthopnea\n  5. Respiration rate \u226520 per minute\n* Additional objective documentation of congestion: Lung or inferior vena cava ultrasound, chest x-ray or elevated filling pressures, if available, at the time of randomization (optional)\n\nExclusion Criteria:\n\nGeneral:\n\n* Any condition which could interfere with the patient's ability to comply with the study\n* In case of female patients, pregnancy or lactation period\n* Participation in an interventional clinical study during the preceding 30 days\n* Previous participation in the same study\n* Unwillingness or inability to complete follow up\n* Active drug or alcohol abuse (smoking allowed)\n\nStudy-specific:\n\n* Acute coronary syndrome requiring intervention during index hospitalization\n* Severe renal dysfunction requiring renal replacement therapy\n* Systolic blood pressure \\< 90 mmHg at the time of randomization\n* Pulmonary hypertension not secondary to left heart disease\n* Pulmonary disease thought to be primarily responsible for symptoms\n* Contraindication to systemic anticoagulation\n* Severe concomitant disease expected to prolong hospitalization or to cause death in \u2264 90 days\n* Sepsis\n* Severe uncorrected valvular stenosis at the time of randomization\n* Active myocarditis\n* Hypertrophic obstructive cardiomyopathy\n* Constrictive pericarditis or restrictive cardiomyopathy\n* Liver cirrhosis due to primary liver disease\\* (\\*Restriction \"due to primary liver disease\" was present after amendment in study protocol version 5.0 but not in version 3.0)\n* Known infection with human immunodeficiency virus (HIV) or active hepatitis C\n* Previous solid organ transplant\n* Presence or requirement for mechanical respiratory support\n* Presence or requirement of a mechanical circulatory support device\n* Need for IV positive inotropic agents at the time of randomization", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Frank Ruschitzka, Prof Dr med", "affiliation": "Universit\u00e4tsspital Z\u00fcrich, Klinik f\u00fcr Kardiologie", "role": "STUDY_CHAIR"}], "locations": [{"facility": "Universit\u00e4tsklinikum Aachen (Med. Klinik II)", "city": "Aachen", "zip": "52074", "country": "Germany", "geoPoint": {"lat": 50.77664, "lon": 6.08342}}, {"facility": "Helios Klinikum Duisburg", "city": "Duisburg", "zip": "47166", "country": "Germany", "geoPoint": {"lat": 51.43247, "lon": 6.76516}}, {"facility": "Helios Klinikum Erfurt GmbH", "city": "Erfurt", "zip": "99089", "country": "Germany", "geoPoint": {"lat": 50.9787, "lon": 11.03283}}, {"facility": "Medizinische Universit\u00e4tsklinik, Innere Medizin III", "city": "Heidelberg", "zip": "69120", "country": "Germany", "geoPoint": {"lat": 49.40768, "lon": 8.69079}}, {"facility": "Helios Klinikum Hildesheim GmbH", "city": "Hildesheim", "zip": "31135", "country": "Germany", "geoPoint": {"lat": 52.15077, "lon": 9.95112}}, {"facility": "Klinikum Stuttgart, Klinik f\u00fcr Nieren-, Hochdruck- und Autoimmunerkrankungen", "city": "Stuttgart", "zip": "70174", "country": "Germany", "geoPoint": {"lat": 48.78232, "lon": 9.17702}}, {"facility": "Falun Hospital", "city": "Falun", "zip": "79182", "country": "Sweden", "geoPoint": {"lat": 60.60357, "lon": 15.62597}}, {"facility": "Danderyds University Hospital", "city": "Stockholm", "zip": "182 88", "country": "Sweden", "geoPoint": {"lat": 59.33258, "lon": 18.0649}}, {"facility": "Karolinska University Hospital Huddinge, Department of Cardiology", "city": "Stockholm", "zip": "SE-14186", "country": "Sweden", "geoPoint": {"lat": 59.33258, "lon": 18.0649}}, {"facility": "Uppsala University Hospital, Department of Cardiology", "city": "Uppsala", "zip": "SE-75185", "country": "Sweden", "geoPoint": {"lat": 59.85882, "lon": 17.63889}}, {"facility": "Universitetssjukhuset \u00d6rebro, Hj\u00e4rtsviktsmottagningen", "city": "\u00d6rebro", "zip": "SE-70185", "country": "Sweden", "geoPoint": {"lat": 59.27412, "lon": 15.2066}}]}, "referencesModule": {"references": [{"pmid": "35061249", "type": "DERIVED", "citation": "Srivastava M, Harrison N, Caetano AFS, Tan AR, Law M. Ultrafiltration for acute heart failure. Cochrane Database Syst Rev. 2022 Jan 21;1(1):CD013593. doi: 10.1002/14651858.CD013593.pub2."}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "Of 62 enrolled patients, 44 were randomized to treatment. 37 patients were included in the safety and full analysis set (SAF/FAS)", "groups": [{"id": "FG000", "title": "Ultrafiltration Group", "description": "Veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm.\n\nCHIARA-System: Treatment with veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm. 1-7 Ultrafiltration sessions (6-10h/session, number of sessions depending on clinical assessment) for at least 1-2 consecutive days and a maximum of 7 days."}, {"id": "FG001", "title": "Control Group (Usual Care IV Diuretics)", "description": "Guideline-directed therapy including IV loop diuretics according to treatment algorithm.\n\nUsual care IV diuretics: Guideline-directed therapy including IV loop diuretics (according to treatment algorithm)"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "comment": "Patients in the FAS", "achievements": [{"groupId": "FG000", "numSubjects": "18"}, {"groupId": "FG001", "numSubjects": "19"}]}, {"type": "COMPLETED", "comment": "Patients in the FAS", "achievements": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "13"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "6"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Of 44 randomized patients, 37 were included in the safety and full analysis set (SAS/ FAS).", "groups": [{"id": "BG000", "title": "Ultrafiltration Group", "description": "Veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm.\n\nCHIARA-System: Treatment with veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm. 1-7 Ultrafiltration sessions (6-10h/session, number of sessions depending on clinical assessment) for at least 1-2 consecutive days and a maximum of 7 days."}, {"id": "BG001", "title": "Control Group (Usual Care IV Diuretics)", "description": "Guideline-directed therapy including IV loop diuretics according to treatment algorithm.\n\nUsual care IV diuretics: Guideline-directed therapy including IV loop diuretics (according to treatment algorithm)"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "19"}, {"groupId": "BG002", "value": "37"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "71.5", "spread": "9.45"}, {"groupId": "BG001", "value": "74.2", "spread": "12.40"}, {"groupId": "BG002", "value": "72.9", "spread": "11"}]}]}]}, {"title": "Age, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<45 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}]}, {"title": "\u2265 45 to <65 years", "measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "8"}]}, {"title": "\u226565 years", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "16"}, {"groupId": "BG002", "value": "28"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "8"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "29"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Caucasian", "categories": [{"measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "19"}, {"groupId": "BG002", "value": "37"}]}]}]}, {"title": "Height", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "cm", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "173.4", "spread": "7.80"}, {"groupId": "BG001", "value": "172.3", "spread": "13.28"}, {"groupId": "BG002", "value": "172.8", "spread": "10.83"}]}]}]}, {"title": "Weight", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "106.4", "spread": "33.17"}, {"groupId": "BG001", "value": "95.6", "spread": "27.42"}, {"groupId": "BG002", "value": "100.9", "spread": "30.42"}]}]}]}, {"title": "Body-Mass-Index (BMI)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "\u226518.5 to <25 kg/m^2", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "5"}]}, {"title": "\u226525 to <30 kg/m^2", "measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "12"}]}, {"title": "\u226530 to <35", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "7"}]}, {"title": "\u226535 to <40 kg/m^2", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "5"}]}, {"title": "\u226540 kg/m^2", "measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "8"}]}]}]}, {"title": "Systolic Blood Pressure (SBP)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mmHg", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "117.6", "spread": "26.23"}, {"groupId": "BG001", "value": "128.5", "spread": "29.84"}, {"groupId": "BG002", "value": "123.2", "spread": "28.30"}]}]}]}, {"title": "Diastolic Blood Pressure (DBP)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mmHg", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "68.4", "spread": "10.62"}, {"groupId": "BG001", "value": "70.4", "spread": "14.68"}, {"groupId": "BG002", "value": "69.4", "spread": "12.73"}]}]}]}, {"title": "Heart rate", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "bpm", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "73.2", "spread": "20.32"}, {"groupId": "BG001", "value": "71.9", "spread": "14.57"}, {"groupId": "BG002", "value": "72.5", "spread": "17.28"}]}]}]}, {"title": "New York Heart Association (NYHA) Functional Classification", "description": "The NYHA system classifies Heart Failure (HF) patients into four categories according to their symptons. Patients graded in NYHA class I show no limitation of physical activity, whereas patients graded in NYHA class IV are unable to carry on physical activity without discomfort.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "NYHA I", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "NYHA II", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}, {"title": "NYHA III", "measurements": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "28"}]}, {"title": "NYHA IV", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "7"}]}, {"title": "Missing", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Heart Failure (HF) Event", "description": "Heart failure hospitalization or unscheduled outpatient or emergency department treatment with IV loop diuretics or ultrafiltration.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "in 90 days after discharge", "groups": [{"id": "OG000", "title": "Ultrafiltration Group", "description": "Veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm.\n\nCHIARA-System: Treatment with veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm. 1-7 Ultrafiltration sessions (6-10h/session, number of sessions depending on clinical assessment) for at least 1-2 consecutive days and a maximum of 7 days."}, {"id": "OG001", "title": "Control Group (Usual Care IV Diuretics)", "description": "Guideline-directed therapy including IV loop diuretics according to treatment algorithm.\n\nUsual care IV diuretics: Guideline-directed therapy including IV loop diuretics (according to treatment algorithm)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "19"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "4"}]}]}]}, {"type": "PRIMARY", "title": "Cardiovascular Death up to 90 Days After Randomization.", "description": "The rationale for the follow up time period of 90 days is that death rates reported in previous acute HF trials indicate that mortality seems to become linear after \\~60-90 days post discharge Collection for Cardiovascular Trials initiative definition of cardiovascular death includes death resulting from an acute myocardial infarction, sudden cardiac death, death due to heart failure, death due to stroke, and death due to other cardiovascular causes", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "in 90 days after discharge", "groups": [{"id": "OG000", "title": "Ultrafiltration Group", "description": "Veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm.\n\nCHIARA-System: Treatment with veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm. 1-7 Ultrafiltration sessions (6-10h/session, number of sessions depending on clinical assessment) for at least 1-2 consecutive days and a maximum of 7 days."}, {"id": "OG001", "title": "Control Group (Usual Care IV Diuretics)", "description": "Guideline-directed therapy including IV loop diuretics according to treatment algorithm.\n\nUsual care IV diuretics: Guideline-directed therapy including IV loop diuretics (according to treatment algorithm)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "19"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "1"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Per patient adverse events were collected from signed informed consent until max 30 days after last clinical Investigation visit.", "description": "Adverse Event Definition and Collection has been according to ISO 14 155 \"Clinical investigation of medical devices for human subjects - Good clinical practice.\"", "eventGroups": [{"id": "EG000", "title": "Ultrafiltration Group", "description": "Veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm.\n\nCHIARA-System: Treatment with veno-venous ultrafiltration (CHIARA-System) complementary to low-dose diuretic therapy according to treatment algorithm. 1-7 Ultrafiltration sessions (6-10h/session, number of sessions depending on clinical assessment) for at least 1-2 consecutive days and a maximum of 7 days.", "deathsNumAffected": 7, "deathsNumAtRisk": 18, "seriousNumAffected": 15, "seriousNumAtRisk": 18, "otherNumAffected": 12, "otherNumAtRisk": 18}, {"id": "EG001", "title": "Control Group (Usual Care IV Diuretics)", "description": "Guideline-directed therapy including IV loop diuretics according to treatment algorithm.\n\nUsual care IV diuretics: Guideline-directed therapy including IV loop diuretics (according to treatment algorithm)", "deathsNumAffected": 2, "deathsNumAtRisk": 19, "seriousNumAffected": 13, "seriousNumAtRisk": 19, "otherNumAffected": 14, "otherNumAtRisk": 19}], "seriousEvents": [{"term": "Cardiac Failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 7, "numAffected": 4, "numAtRisk": 19}]}, {"term": "Atrioventricular", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Cardiogenic shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Cardiovascular", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Sinoatrial block", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Ventricular", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Acute kidney", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 19}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 19}]}, {"term": "Nephrotic", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Erysipelas", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Staphylococcal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Rib fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Vascular", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Fluid overload", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Dementia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Delirium", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Suicide attempt", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Catheter", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Stent placement", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Abdominal wall", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Echocardiogram", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Oxygen saturation", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Arthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Breast cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}, {"term": "Device dislocation", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Pneumothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 19}]}, {"term": "Loss of personal", "organSystem": "Social circumstances", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 19}]}], "otherEvents": [{"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 19}]}, {"term": "Cyst", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Injection site pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Therapeutic product ineffective", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Vessel puncture site haematoma", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 19}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Bradycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Bundle branch block left", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 19}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Dyspnoea exertional", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Emphysema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Haemothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Pulmonary hypertension", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Tachypnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 19}]}, {"term": "Chronic kidney disease", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Haematuria", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Urinary Incontinence", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Urinary retention", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 19}]}, {"term": "Haematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Peripheral arterial occlusive disease", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Thrombophlebitis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Fall", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Post procedural haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Skin laceration", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Vascular access complication", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Wound", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Escherichia infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Escherichia urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Arthralgia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Back pain", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Flank pain", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Musculoskeletal pain", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Pain in extremity", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Dementia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Dementia Alzheimer's type", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Presyncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Cardiac resynchronisation therapy", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Cardioversion", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Dialysis device insertion", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Percutaneous coronary intervention", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Blood creatinine increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Glomerular filtration rate decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Haemoglobin decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Stasis dermatitis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Decubitis ulcer", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Skin lesion", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Skin ulcer", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Vertigo", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 19}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Needle issue", "organSystem": "Product Issues", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}, {"term": "Delirium", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 22.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 19}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Due to the premature termination of the study and a resulting sample size of 37 patients in both analyses sets no statistical testing for any study endpoint has been applied. All study objectives were analyzed purely descriptively, continuous data with sample statistics, categorical data by frequency tables."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "LTE60", "restrictiveAgreement": true}, "pointOfContact": {"title": "Dr. Jennifer Braun", "organization": "Fresenius Medical Care Deutschland GmbH", "email": "Jennifer.Braun@fmc-ag.com", "phone": "+49 6172 609 93488"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2018-12-19", "uploadDate": "2020-12-15T06:59", "filename": "Prot_SAP_000.pdf", "size": 512239}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M16355", "name": "Syndrome", "relevance": "LOW"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M29439", "name": "Cardio-Renal Syndrome", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "BXS", "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000004232", "term": "Diuretics"}], "ancestors": [{"id": "D000045283", "term": "Natriuretic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M7411", "name": "Diuretics", "asFound": "Scanner", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}